Skip to main content

A 'one-off opportunity:' Drug company hikes price of blood pressure drugs after competitors' drugs recalled

An India-based pharmaceutical company tripled the price of its valsartan after competitors were forced to take theirs off the market.

     
 
 


from USATODAY - News Top Stories http://bit.ly/2SjEBVC
Labels:

Comments

Post a Comment

Popular posts from this blog

Despite Unleashing COVID-19, Expert Predicts China Could Emerge from Pandemic with Even Stronger Hold on Other Nations

Tensions between the US and China are growing, fueled by COVID-19 and accusations of dishonesty. One result is Americans are suing Beijing, seeking to hold it accountable for the worldwide pandemic. Those efforts could backfire, however, such that China not only evades consequences but potentially benefits from the pandemic. from CBNNews.com https://ift.tt/3aVp0Ba
Post a Comment
Read more